What is the step‑by‑step algorithm for diagnosing tuberculosis in a patient with a cough lasting ≥ two weeks, incorporating constitutional symptoms, risk‑factor assessment, and appropriate investigations?

Diagnostic Algorithm for Tuberculosis in Patients with Cough ≥ 2 Weeks

Any patient presenting with cough lasting 2–3 weeks should undergo chest radiography, and if findings are suggestive of TB or the patient has HIV infection, collect three sputum specimens for AFB smear microscopy, culture, and rapid molecular testing (Xpert MTB/RIF). 1

Step 1: Initial Clinical Assessment and Risk Stratification

Symptom Evaluation

• Screen for constitutional symptoms beyond cough: fever, night sweats, weight loss, and hemoptysis 1
• Cough duration of ≥ 2 weeks is the threshold for TB evaluation—there is no evidence that waiting for 3 or 4 weeks improves diagnostic accuracy, and earlier screening may prevent transmission 1
• In HIV-positive patients, the presence of any WHO-endorsed symptom (cough plus fever, night sweats, hemoptysis, or weight loss) significantly increases diagnostic sensitivity and warrants immediate TB workup 1

High-Risk Population Identification

Proceed with TB diagnostic evaluation if the patient has any of the following risk factors: 1

• Recent exposure to active pulmonary TB case
• History of positive tuberculin skin test or IGRA
• HIV infection or AIDS
• Injection or non-injection drug use
• Foreign birth with immigration within 5 years from high TB burden region
• Residence or employment in congregate settings (correctional facilities, shelters, long-term care)
• Medical risk factors: diabetes mellitus, prolonged corticosteroid therapy, chronic renal failure, hematologic malignancies, weight >10% below ideal, silicosis, gastrectomy
• Homelessness or medically underserved low-income population

Step 2: Chest Radiography

Obtain chest X-ray immediately in any patient meeting Step 1 criteria 1

Radiographic Features Suggestive of Active TB:

• Infiltrates with or without cavitation in upper lobes or superior segments of lower lobes 1
• Cavitary air-space disease in apical-posterior segments 2
• Lobar pneumonia with hilar or mediastinal adenopathy 2
• Miliary pattern 3

Critical Caveat:

• Chest X-ray alone has poor specificity for distinguishing active from inactive TB—if findings are equivocal, obtain chest CT for higher specificity 2
• In immunocompromised patients (HIV with CD4 <200, anti-TNF therapy), chest X-rays may appear normal despite active TB—CT is mandatory in this population 2

Step 3: Microbiological Testing

Sputum Collection Protocol

Collect at least three sputum specimens on different days for comprehensive testing: 1, 2

• One specimen for rapid molecular testing (Xpert MTB/RIF) immediately
• All specimens for AFB smear microscopy
• All specimens for liquid culture (MGIT) with drug susceptibility testing

If spontaneous sputum production is inadequate, use sputum induction with hypertonic saline 2, 4

Testing Priorities by Clinical Scenario:

For patients at low risk of drug-resistant TB: 1

• Xpert MTB/RIF should replace sputum microscopy as initial test when available
• Chest X-ray should be performed when resources allow

For patients at high risk of drug-resistant TB (prior TB treatment, contact with drug-resistant case, high-prevalence region): 1, 5

• Xpert MTB/RIF immediately on respiratory specimens
• Simultaneously send samples for liquid culture with phenotypic drug susceptibility testing
• Start standard four-drug first-line therapy pending confirmatory results

Understanding Test Limitations:

• Xpert MTB/RIF detects only 41–46% of smear-negative pulmonary TB cases—a negative result does not rule out disease 2
• Only 50% of culture-positive TB patients have positive AFB smears—culture remains the gold standard 2, 4
• Never start MDR-TB treatment based solely on Xpert rifampin resistance without phenotypic confirmation 5

Step 4: Special Populations and Modified Algorithms

HIV-Positive Patients with Unexplained Cough and Fever:

Obtain chest radiograph and three sputum specimens for AFB smear, culture, and Xpert MTB/RIF regardless of other symptoms 1

• The WHO symptom screen (cough, fever, night sweats, hemoptysis, weight loss) has improved sensitivity in this population 1, 2
• Pregnant HIV-positive women are more likely to be asymptomatic—the symptom screen is not reliable enough in this subgroup 1

Community-Acquired Pneumonia Not Improving After 7 Days:

In high-risk patients with CAP failing empiric antibiotic therapy, obtain chest radiograph and three sputum specimens for TB evaluation 1, 3

• Any CAP patient with upper lobe infiltrate, cavitation, hemoptysis, or symptoms >1 month warrants TB investigation 3

Incidental Chest X-Ray Findings:

In high-risk patients with radiographic findings suggestive of TB but minimal symptoms, review previous chest radiographs if available and collect three sputum specimens 1

Step 5: Decision to Initiate Empiric Treatment

Start Empiric TB Treatment Immediately If:

• Progressive constitutional symptoms (weight loss, night sweats, fever, hemoptysis) 2
• HIV-positive status with low CD4 count 2
• Cavitary disease on chest X-ray 2
• Close TB contact with high clinical suspicion 2
• Clinical deterioration while awaiting culture results 4

Wait for Culture Results (3–8 Weeks) If:

• Clinical suspicion is low and patient is stable 2
• Cough has spontaneously resolved (atypical for active TB) 2

Standard Treatment Regimen:

HRZE for 2 months (isoniazid, rifampin, pyrazinamide, ethambutol), followed by isoniazid and rifampin for 4 months 2, 4, 6

Step 6: Public Health Reporting and Contact Investigation

• Report all suspected TB cases to local health authorities even before culture confirmation 2
• Evaluate close contacts for TB exposure if diagnosis is confirmed 2
• Consider directly observed therapy (DOT) to ensure adherence 2

Critical Pitfalls to Avoid

• Do not assume negative Xpert MTB/RIF equals no TB—culture remains the gold standard, particularly in paucibacillary disease 2, 4
• Do not delay sputum collection while continuing empiric antibiotic trials—this wastes valuable diagnostic time 4
• Never add a single drug to a failing or suspected regimen—this rapidly creates drug resistance 2, 4
• Do not rely on chest X-ray alone to exclude active TB—obtain CT if findings are equivocal 2
• Do not skip HIV testing—it is mandatory in all TB suspects 4

Alternative Diagnoses to Consider

If sputum samples are non-diagnostic and clinical suspicion remains high, perform bronchoscopy with bronchoalveolar lavage and biopsy 4

• Sarcoidosis causes noncaseating granulomas and cough in 40–80% of symptomatic patients 4